3i is a leading international venture capital company with U.S. offices in Menlo
Park, CA and Waltham, MA. Operating since 1945, 3i has invested worldwide over $31
billion, including co-investment funds, with a total staff of 700 employees operating
out of 30 offices in 14 countries. 3i leverages this worldwide presence to add value
to its portfolio companies and investment partners. In the United States, 3i concentrates
on early and late stage technology investments in companies with the potential to
be leaders in their markets. Outside the US, 3i invests broadly in buyouts, growth
capital and venture capital. Since opening its US businesses in 1999, 3i has become
one of the most active early and late stage VCs in the US. Recent investments in
early stage companies include BlueLithium, Bitfone, Peerflix, Crystal IS, TransMedics,
NeoGuide Systems, DAFCA, SiGe Semiconductor, Discera, and OmniGuide. 3i has been
equally active on the late stage, with recent investments in Vonage, Skystream Networks,
Speakeasy, Impact Rx, Merchant e-Solutions, Swissray, Top Layer, and Vette Corp.
Visit 3i
Investor Growth Capital is a venture capital and private equity advisory group wholly
owned by Investor AB, a large industrial holding company and leading shareholder
in several multinational companies, including ABB, AstraZeneca, Ericsson, SAAB and
SEB. For almost a century, Investor AB's business concept has been to build best-in-
class companies in sectors where the group has a strong knowledge and networking
advantage. Investor Growth Capital shares this investment philosophy and leverages
Investor AB's extensive global network of companies and senior managers. Investor
Growth Capital has a capital allocation of USD 1.8 billion and focuses on investments
in growth companies in the IT and healthcare sectors in Europe, North America and
Asia. Recent investments include eSilicon Corporation, Greenway Medical Technologies,
Innovative Micro Technology, Picolight, and Visiprise.
Visit IGC